Methotrexate Drug Demand Soaring Due to Chronic Disease Burden and Biosimilar Adoption - Market to Reach US$ 1.058 Billion by 2034 [Yahoo! Finance]
Cumberland Pharmaceuticals Inc. (CPIX)
Last cumberland pharmaceuticals inc. earnings: 3/18 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.shareholder.com/cpix/index.cfm
Company Research
Source: Yahoo! Finance
Gain access to our in-depth report, which explores demand and supply trends, technology roadmap, market background, key drivers, restraints, opportunities, and valuable insights from an Investment Feasibility Matrix, PESTLE analysis, Porter's Five Forces analysis, and more. Download a Sample Report to get a glimpse of the valuable information available. NEWARK, Del. March 19, 2024 /PRNewswire/ -- Future Market Insights anticipates the methotrexate drug market to reach US$621.3 million in 2024 . Market growth is projected to experience a increase from 2024 to 2034, with a CAGR of 5.5%, compared to 7.2% in 2023. This translates to a projected market value of US$1,058 million by 2034 Demand-side Trends in The Methotrexate Drug Industry the increasing prevalence of chronic diseases the rise of biosimilar advances in drug delivery systems the growing awareness and acceptance of alternative therapies the amplifying number of clinical trials and research studies on methotrexate
Show less
Read more
Impact Snapshot
Event Time:
CPIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPIX alerts
High impacting Cumberland Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
CPIX
News
- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS [Yahoo! Finance]Yahoo! Finance
- NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSPR Newswire
CPIX
Sec Filings
- 3/26/24 - Form 4
- 3/26/24 - Form 4
- 3/26/24 - Form 4
- CPIX's page on the SEC website